Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)

FDA 510(k) K212778 · Abbott Molecular, Inc.

Substantially Equivalent

510(k) numberK212778

Submission

Device name
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)
Applicant
Abbott Molecular, Inc.
Des Plaines, IL, US
Received
September 1, 2021
Decision date
July 15, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QLX – Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3183
Specialty
Microbiology

A quantitative viral nucleic acid test for transplant patient management is identified as a device intended for prescription use in the detection of viral pathogens by measurement of viral deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) using specified specimen processing, amplification, and detection instrumentation. The test is intended for use as an aid in the management of transplant…

Other 510(k)s with product code QLX

510(k)DeviceApplicantDecision
K243489Alinity m EBV (09N43-095)QLX · Traditional Abbott Molecular, Inc.07/28/2025SE
K203220cobas BKVQLX · Traditional Roche Molecular Systems, Inc.01/29/2021SE

More from Roche Molecular Systems, Inc.

510(k)DeviceDecision
K252102Alinity m HCVMZP · Traditional 09/25/2025SE
K243489Alinity m EBV (09N43-095)QLX · Traditional 07/28/2025SE
K243485Alinity m CMVPAB · Traditional 07/01/2025SE
K241921Alinity m BKVQMI · Traditional 03/24/2025SE
K241573Alinity m Resp-4-PlexQOF · Traditional 02/14/2025SE
K243410simpli-COLLECT STI TestQYA · Traditional 01/30/2025SE
K241580Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086)QQX · Traditional 12/06/2024SE
K233349Alinity m HSV 1 & 2 / VZVPGI · Traditional 05/03/2024SE
K222379Alinity m STI AssayQEP · Traditional 03/03/2023SE
K202977Alinity m STI AssayQEP · Traditional 04/29/2022SE

Questions and answers

When was Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) cleared by the FDA?

Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778) received a 510(k) decision of Substantially Equivalent on July 15, 2022, 317 days after the submission was received.

What is the product code of K212778?

The FDA product code is QLX – Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna, a Class II (moderate risk) device regulated under 21 CFR 866.3183.